• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The bcr-c-abl tyrosine kinase activity is extinguished by TPA in K562 leukemia cells.

作者信息

Alitalo R

机构信息

Transplantation Laboratory, University of Helsinki, Finland.

出版信息

FEBS Lett. 1987 Oct 5;222(2):293-8. doi: 10.1016/0014-5793(87)80389-7.

DOI:10.1016/0014-5793(87)80389-7
PMID:3477472
Abstract

Tyrosine kinase activity is associated with the transforming potential of several oncogenes. Human chronic myeloid leukemia (CML) cells and cell lines have been shown to contain an active bcr-c-abl p210 tyrosine kinase as a consequence of the Philadelphia chromosomal translocation. In the present work the activity of the c-abl and c-src oncogene-encoded tyrosine kinase was investigated during phorbol diester (TPA) induced differentiation of the K562 CML cells. The high tyrosine kinase activity of p210bcr-c-abl is strongly reduced during the initial 24 h of TPA treatment. In contrast, the activity of the c-src tyrosine kinase is not changed. No change occurs in the expression of the c-abl-specific RNAs during this period. Following the reduction of bcr-c-abl kinase activity, cell proliferation is arrested and megakaryoblastic antigens appear on the cells. Sodium butyrate caused a slight decrease in growth rate and of bcr-c-abl kinase activity during erythroid differentiation whereas no changes in c-src or c-abl tyrosine kinase activities were seen in DMSO-treated control cells.

摘要

相似文献

1
The bcr-c-abl tyrosine kinase activity is extinguished by TPA in K562 leukemia cells.
FEBS Lett. 1987 Oct 5;222(2):293-8. doi: 10.1016/0014-5793(87)80389-7.
2
Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.慢性粒细胞白血病患者费城染色体阳性细胞各亚型中P210bcr-abl酪氨酸蛋白激酶活性分析
Cancer Res. 1987 Mar 15;47(6):1731-9.
3
Effect of differentiation-inducing agents on oncogene expression in a chronic myelogenous leukemia cell line.分化诱导剂对慢性粒细胞白血病细胞系癌基因表达的影响。
Cancer. 1988 Sep 15;62(6):1171-8. doi: 10.1002/1097-0142(19880915)62:6<1171::aid-cncr2820620621>3.0.co;2-8.
4
Inhibition of phosphorylation of p160 BCR within p210 BCR-ABL complexes during early stages of phorbol ester-induced differentiation of K562 cells.
Cell Growth Differ. 1993 Jul;4(7):581-8.
5
Phosphotyrosine antibodies identify the p210c-abl tyrosine kinase and proteins phosphorylated on tyrosine in human chronic myelogenous leukemia cells.磷酸酪氨酸抗体可识别人类慢性粒细胞白血病细胞中的p210c-abl酪氨酸激酶以及酪氨酸磷酸化蛋白。
Mol Cell Biol. 1986 May;6(5):1803-11. doi: 10.1128/mcb.6.5.1803-1811.1986.
6
Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.Bcr、Abl和Bcr-Abl蛋白在正常细胞和白血病细胞中的亚细胞定位以及表达与髓系分化的相关性。
J Clin Invest. 1993 Oct;92(4):1925-39. doi: 10.1172/JCI116786.
7
The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.BCR/ABL癌基因的P190、P210和P230形式在小鼠中诱导出类似慢性髓性白血病的综合征,但具有不同的淋巴细胞白血病致瘤活性。
J Exp Med. 1999 May 3;189(9):1399-412. doi: 10.1084/jem.189.9.1399.
8
Induced dendritic cell differentiation of chronic myeloid leukemia blasts is associated with down-regulation of BCR-ABL.慢性髓性白血病母细胞的诱导树突状细胞分化与BCR-ABL的下调有关。
J Immunol. 2003 Aug 15;171(4):1780-91. doi: 10.4049/jimmunol.171.4.1780.
9
Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL.abl酪氨酸激酶的独特形式可区分Ph1阳性慢性粒细胞白血病与Ph1阳性急性淋巴细胞白血病。
Science. 1987 Jan 2;235(4784):85-8. doi: 10.1126/science.3541203.
10
Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis.抑制ABL激酶活性可阻断BCR/ABL+白血病细胞的增殖并诱导细胞凋亡。
Blood Cells Mol Dis. 1997 Dec;23(3):380-94. doi: 10.1006/bcmd.1997.0155.

引用本文的文献

1
Differentiation of acute and chronic myeloid leukemic blasts into the dendritic cell lineage: analysis of various differentiation-inducing signals.急性和慢性髓系白血病原始细胞向树突状细胞谱系的分化:多种分化诱导信号的分析
Cancer Immunol Immunother. 2005 Jan;54(1):25-36. doi: 10.1007/s00262-004-0562-4.
2
Putative tyrosine kinases expressed in K-562 human leukemia cells.在K-562人白血病细胞中表达的假定酪氨酸激酶。
Proc Natl Acad Sci U S A. 1990 Nov;87(22):8913-7. doi: 10.1073/pnas.87.22.8913.